Although a wide diversity in the functional output of PTPN11 gene disease-associated mutations exists, gain-of-function PTPN11 mutations are relatively frequent in human cancer, mainly targeting two hot-spots encoding specific regions at the N-SH2 and PTP domains of the enzyme (https://cancer.sanger.ac.uk). Here, PTPN11 is linked to cancer.